Methylparaben is suspected of causing endocrine-disrupting effects, according to European Commission Annex 13. Includes both Category 1 (evidence for endocrine disruption in living organisms) and Category 2 (evidence of potential to cause endocrine disruption in in vitro studies)
Methylparaben (or its metabolites) is frequently detected in human blood or urine, indicating significant U.S. population exposure.
It is not on any of GoodGuide’s lists of toxic chemicals which cause suspected or recognized health effects.
It has not been detected in human tissue or urine.